Сообщение №67543832
| 1 +0−0 | Michael Shulman | 11:52:25 22/10/2020 |
Комментарий удалён. | ||
Кстати вот результаты расследования Following careful assessment of this case in Brazil, there have been no concerns about safety of the clinical trial and the independent review in addition to the Brazilian regulator have recommended that the trial should continue" | ||